1. Home
  2. GRFS vs SAIC Comparison

GRFS vs SAIC Comparison

Compare GRFS & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • SAIC
  • Stock Information
  • Founded
  • GRFS 1940
  • SAIC 1969
  • Country
  • GRFS Spain
  • SAIC United States
  • Employees
  • GRFS N/A
  • SAIC N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • SAIC EDP Services
  • Sector
  • GRFS Health Care
  • SAIC Technology
  • Exchange
  • GRFS Nasdaq
  • SAIC Nasdaq
  • Market Cap
  • GRFS 5.1B
  • SAIC 5.1B
  • IPO Year
  • GRFS 2006
  • SAIC N/A
  • Fundamental
  • Price
  • GRFS $7.27
  • SAIC $112.53
  • Analyst Decision
  • GRFS
  • SAIC Buy
  • Analyst Count
  • GRFS 0
  • SAIC 8
  • Target Price
  • GRFS N/A
  • SAIC $142.25
  • AVG Volume (30 Days)
  • GRFS 1.2M
  • SAIC 1.1M
  • Earning Date
  • GRFS 07-28-2022
  • SAIC 03-17-2025
  • Dividend Yield
  • GRFS N/A
  • SAIC 1.31%
  • EPS Growth
  • GRFS 283.33
  • SAIC N/A
  • EPS
  • GRFS 0.24
  • SAIC 7.17
  • Revenue
  • GRFS $7,467,006,939.00
  • SAIC $7,479,000,000.00
  • Revenue This Year
  • GRFS $8.45
  • SAIC $4.13
  • Revenue Next Year
  • GRFS $7.08
  • SAIC $2.52
  • P/E Ratio
  • GRFS $35.68
  • SAIC $15.69
  • Revenue Growth
  • GRFS 9.41
  • SAIC 0.47
  • 52 Week Low
  • GRFS $5.79
  • SAIC $94.68
  • 52 Week High
  • GRFS $9.96
  • SAIC $156.34
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 37.73
  • SAIC 59.09
  • Support Level
  • GRFS $7.13
  • SAIC $108.31
  • Resistance Level
  • GRFS $7.81
  • SAIC $109.69
  • Average True Range (ATR)
  • GRFS 0.24
  • SAIC 4.28
  • MACD
  • GRFS -0.11
  • SAIC 0.58
  • Stochastic Oscillator
  • GRFS 13.33
  • SAIC 55.61

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, the company offers engineering, systems integration, and information technology for large government projects and a broad range of services with an emphasis on higher-end technology services. The company's end-to-end enterprise IT offerings span the entire spectrum of customers' IT infrastructure.

Share on Social Networks: